Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intra-individual qualitative and quantitative comparison of [68Ga]Ga-DOTATATE PET/CT and PET/MRI.
Lens G, Ahmadi Bidakhvidi N, Vandecaveye V, Grauwels S, Laenen A, Deckers W, Peeters R, Dresen RC, Dekervel J, Verslype C, Nackaerts K, Clement PM, Van Cutsem E, Koole M, Goffin K, Van Laere K, Deroose CM. Lens G, et al. Among authors: clement pm. Ther Adv Med Oncol. 2023 Oct 24;15:17588359231189133. doi: 10.1177/17588359231189133. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37885461 Free PMC article.
[68Ga]Ga-DOTATATE-avid tumor volume, uptake and inflammation-based index correlate with survival in neuroendocrine tumor patients treated with [177Lu]Lu-DOTATATE PRRT.
Pauwels E, Dekervel J, Verslype C, Clement PM, Dooms C, Baete K, Goffin K, Jentjens S, Van Laere K, Van Cutsem E, Deroose CM. Pauwels E, et al. Among authors: clement pm. Am J Nucl Med Mol Imaging. 2022 Oct 15;12(5):152-162. eCollection 2022. Am J Nucl Med Mol Imaging. 2022. PMID: 36419585 Free PMC article.
[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients.
Pauwels E, Celen S, Baete K, Koole M, Bechter O, Bex M, Renard M, Clement PM, Jentjens S, Serdons K, Van Laere K, Bormans G, Deroose CM. Pauwels E, et al. Among authors: clement pm. Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1134-1145. doi: 10.1007/s00259-022-06046-7. Epub 2022 Nov 26. Eur J Nucl Med Mol Imaging. 2023. PMID: 36435928
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients.
Boeckxstaens L, Pauwels E, Vandecaveye V, Deckers W, Cleeren F, Dekervel J, Vandamme T, Serdons K, Koole M, Bormans G, Laenen A, Clement PM, Geboes K, Van Cutsem E, Nackaerts K, Stroobants S, Verslype C, Van Laere K, Deroose CM. Boeckxstaens L, et al. Among authors: clement pm. EJNMMI Res. 2023 Jun 1;13(1):53. doi: 10.1186/s13550-023-01003-3. EJNMMI Res. 2023. PMID: 37261615 Free PMC article.
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort.
Thijssen S, Wildiers H, Punie K, Beuselinck B, Clement P, Remmerie C, Berteloot P, Han S, Van Nieuwenhuysen E, Van Gorp T, Vergote I, Smeets A, Nevelsteen I, Floris G, Weltens C, Menten J, Janssen H, Laenen A, Neven P. Thijssen S, et al. J Cancer Res Clin Oncol. 2021 Apr;147(4):1041-1048. doi: 10.1007/s00432-020-03487-1. Epub 2021 Jan 20. J Cancer Res Clin Oncol. 2021. PMID: 33471187 Clinical Trial.
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy.
Franken A, Bila M, Mechels A, Kint S, Van Dessel J, Pomella V, Vanuytven S, Philips G, Bricard O, Xiong J, Boeckx B, Hatse S, Van Brussel T, Schepers R, Van Aerde C, Geurs S, Vandecaveye V, Hauben E, Vander Poorten V, Verbandt S, Vandereyken K, Qian J, Tejpar S, Voet T, Clement PM, Lambrechts D. Franken A, et al. Among authors: clement pm. Immunity. 2024 Mar 12;57(3):541-558.e7. doi: 10.1016/j.immuni.2024.02.007. Epub 2024 Mar 4. Immunity. 2024. PMID: 38442708
[No title available]
[No authors listed] [No authors listed] PMID: 36112248
102 results